Iago Justo1, Carlos Jiménez-Romero2, Alejandro Manrique2, Oscar Caso2, Jorge Calvo2, Felix Cambra2, Alberto Marcacuzco2. 1. Unit of HPB Surgery and Abdominal Organ Transplantation, Doce de Octubre University Hospital, Department of Surgery, Faculty of Medicine, Complutense University, 4ª Planta. Ctra Andalucía Km 5,4, 28041, Madrid, Spain. iagojusto@hotmail.com. 2. Unit of HPB Surgery and Abdominal Organ Transplantation, Doce de Octubre University Hospital, Department of Surgery, Faculty of Medicine, Complutense University, 4ª Planta. Ctra Andalucía Km 5,4, 28041, Madrid, Spain.
Abstract
BACKGROUND: Liver abscess after orthotopic liver transplantation (OLT) is a rare, life-threatening complication. The aim of this study is to analyze the incidence, risk factors, clinical manifestations, treatment and outcomes of liver abscesses after OLT. METHODS: We perform a retrospective review of the patients who developed one or more liver abscesses among a series of 984 patients who underwent OLT between January 2000 and December 2016. RESULTS: Fourteen patients (1.5%) developed 18 episodes of liver abscesses, and the median time from OLT to the diagnosis of liver abscess was 39.7 months. Major predisposing factors were biliary strictures in 11 patients, hepatic artery thrombosis in 8, re-OLT in 3, choledochojejunostomy in 2, living donor OLT in 2, donor after cardiac death in 1, split liver in 1, and liver biopsy in 1. All patients were managed by intravenous antibiotics; percutaneous drainage was performed in 10 patients, while 2 patients underwent re-OLT. The mortality rate related to liver abscesses was 21.4%. The mean hospital stay was 30 ± 19 days, and during a mean follow-up of 93 ± 78 months, three other patients died. CONCLUSIONS: Liver abscesses must be managed with antibiotic therapy and percutaneous drainage, but when these conservative measures fail (persistent abscess and sepsis), a re-OLT must be performed in order to prevent the high mortality associated with this severe complication.
BACKGROUND:Liver abscess after orthotopic liver transplantation (OLT) is a rare, life-threatening complication. The aim of this study is to analyze the incidence, risk factors, clinical manifestations, treatment and outcomes of liver abscesses after OLT. METHODS: We perform a retrospective review of the patients who developed one or more liver abscesses among a series of 984 patients who underwent OLT between January 2000 and December 2016. RESULTS: Fourteen patients (1.5%) developed 18 episodes of liver abscesses, and the median time from OLT to the diagnosis of liver abscess was 39.7 months. Major predisposing factors were biliary strictures in 11 patients, hepatic artery thrombosis in 8, re-OLT in 3, choledochojejunostomy in 2, living donor OLT in 2, donor after cardiac death in 1, split liver in 1, and liver biopsy in 1. All patients were managed by intravenous antibiotics; percutaneous drainage was performed in 10 patients, while 2 patients underwent re-OLT. The mortality rate related to liver abscesses was 21.4%. The mean hospital stay was 30 ± 19 days, and during a mean follow-up of 93 ± 78 months, three other patients died. CONCLUSIONS:Liver abscesses must be managed with antibiotic therapy and percutaneous drainage, but when these conservative measures fail (persistent abscess and sepsis), a re-OLT must be performed in order to prevent the high mortality associated with this severe complication.
Authors: L De Carlis; A O Slim; A Giacomoni; F DiBenedetto; V Pirotta; A Lauterio; C Sammartino; G F Rondinara; D Forti Journal: Transplant Proc Date: 2001 Feb-Mar Impact factor: 1.066
Authors: J M Rabkin; S L Orloff; C L Corless; K G Benner; K D Flora; H R Rosen; F S Keller; R E Barton; P C Lakin; B D Petersen; R R Saxon; A J Olyaei Journal: Am J Surg Date: 1998-05 Impact factor: 2.565
Authors: P A Sheiner; C V Varma; J V Guarrera; J Cooper; M Garatti; S Emre; S R Guy; M E Schwartz; C M Miller Journal: Transplantation Date: 1997-11-15 Impact factor: 4.939
Authors: David P Foley; Luis A Fernandez; Glen Leverson; L Thomas Chin; Nancy Krieger; Jeffery T Cooper; Brian D Shames; Yolanda T Becker; Jon S Odorico; Stuart J Knechtle; Hans W Sollinger; Munci Kalayoglu; Anthony M D'Alessandro Journal: Ann Surg Date: 2005-11 Impact factor: 12.969
Authors: Emad Hamdy Gad; Eslam Ayoup; Amr M Aziz; Tarek Ibrahim; Mostafa Elhelbawy; Mohammed Al-Sayed Abd-Elsamee; Ahmed Nabil Sallam Journal: Ann Med Surg (Lond) Date: 2022-04-14